Cargando…

Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database

Background: Underutilization of operative management of early stage pancreatic cancer is associated with sociodemographic variables, including age, race, facility type, insurance, and education. It is currently unclear how these variables are associated with survival in patients who undergo surgery....

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, Michael D., Miller-Ocuin, Jennifer L., Driedger, Michael R., Beckman, Michael J., McKillop, Iain H., Baker, Erin H., Martinie, John B., Vrochides, Dionisios, Iannitti, David A., Ocuin, Lee M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520653/
https://www.ncbi.nlm.nih.gov/pubmed/32999955
http://dx.doi.org/10.1089/pancan.2020.0011
_version_ 1783587819481989120
author Watson, Michael D.
Miller-Ocuin, Jennifer L.
Driedger, Michael R.
Beckman, Michael J.
McKillop, Iain H.
Baker, Erin H.
Martinie, John B.
Vrochides, Dionisios
Iannitti, David A.
Ocuin, Lee M.
author_facet Watson, Michael D.
Miller-Ocuin, Jennifer L.
Driedger, Michael R.
Beckman, Michael J.
McKillop, Iain H.
Baker, Erin H.
Martinie, John B.
Vrochides, Dionisios
Iannitti, David A.
Ocuin, Lee M.
author_sort Watson, Michael D.
collection PubMed
description Background: Underutilization of operative management of early stage pancreatic cancer is associated with sociodemographic variables, including age, race, facility type, insurance, and education. It is currently unclear how these variables are associated with survival in patients who undergo surgery. Methods: Patients with clinical stage I pancreatic adenocarcinoma were identified within the National Cancer Database (2010–2016). Utilization of surgery and nonoperative management was determined. Nonclinical factors associated with nonoperative management were identified by multivariable analysis. The association between nonclinical factors and survival was assessed in patients who received operative management. Results: A total of 17,833 patients with clinical stage I pancreatic cancer were identified, and 41.2% underwent operative intervention. Approximately 46% of nonoperatively managed patients lacked a contraindication. Operatively managed patients had longer overall survival (OS) than those who were nonoperatively managed or untreated (25.1 months vs. 11.1 months vs. 5.1 months, p < 0.0001). Factors associated with nonoperative management included age, black/Hispanic race, nonacademic facilities, nonprivate health insurance, lower education level, and lower income. In operatively managed patients, nonclinical factors associated with lower OS included Medicaid (hazard ratio [HR] 1.27) and treatment at nonacademic facilities (HR 1.20–1.22). Patients on Medicaid received less adjuvant therapy and had higher 30- and 90-day mortality rates. Patients treated at nonacademic facilities received less neoadjuvant therapy, had worse pathologic outcomes, and had higher 30- and 90-day mortality rates. Conclusions: Surgical management is underutilized in clinical stage I pancreatic cancer. Primary insurance payor and facility type appear to be associated with OS in patients who undergo operative management.
format Online
Article
Text
id pubmed-7520653
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-75206532020-09-29 Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database Watson, Michael D. Miller-Ocuin, Jennifer L. Driedger, Michael R. Beckman, Michael J. McKillop, Iain H. Baker, Erin H. Martinie, John B. Vrochides, Dionisios Iannitti, David A. Ocuin, Lee M. J Pancreat Cancer Original Article Background: Underutilization of operative management of early stage pancreatic cancer is associated with sociodemographic variables, including age, race, facility type, insurance, and education. It is currently unclear how these variables are associated with survival in patients who undergo surgery. Methods: Patients with clinical stage I pancreatic adenocarcinoma were identified within the National Cancer Database (2010–2016). Utilization of surgery and nonoperative management was determined. Nonclinical factors associated with nonoperative management were identified by multivariable analysis. The association between nonclinical factors and survival was assessed in patients who received operative management. Results: A total of 17,833 patients with clinical stage I pancreatic cancer were identified, and 41.2% underwent operative intervention. Approximately 46% of nonoperatively managed patients lacked a contraindication. Operatively managed patients had longer overall survival (OS) than those who were nonoperatively managed or untreated (25.1 months vs. 11.1 months vs. 5.1 months, p < 0.0001). Factors associated with nonoperative management included age, black/Hispanic race, nonacademic facilities, nonprivate health insurance, lower education level, and lower income. In operatively managed patients, nonclinical factors associated with lower OS included Medicaid (hazard ratio [HR] 1.27) and treatment at nonacademic facilities (HR 1.20–1.22). Patients on Medicaid received less adjuvant therapy and had higher 30- and 90-day mortality rates. Patients treated at nonacademic facilities received less neoadjuvant therapy, had worse pathologic outcomes, and had higher 30- and 90-day mortality rates. Conclusions: Surgical management is underutilized in clinical stage I pancreatic cancer. Primary insurance payor and facility type appear to be associated with OS in patients who undergo operative management. Mary Ann Liebert, Inc., publishers 2020-09-21 /pmc/articles/PMC7520653/ /pubmed/32999955 http://dx.doi.org/10.1089/pancan.2020.0011 Text en © Michael D. Watson et al., 2020; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Watson, Michael D.
Miller-Ocuin, Jennifer L.
Driedger, Michael R.
Beckman, Michael J.
McKillop, Iain H.
Baker, Erin H.
Martinie, John B.
Vrochides, Dionisios
Iannitti, David A.
Ocuin, Lee M.
Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
title Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
title_full Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
title_fullStr Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
title_full_unstemmed Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
title_short Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
title_sort factors associated with treatment and survival of early stage pancreatic cancer in the era of modern chemotherapy: an analysis of the national cancer database
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520653/
https://www.ncbi.nlm.nih.gov/pubmed/32999955
http://dx.doi.org/10.1089/pancan.2020.0011
work_keys_str_mv AT watsonmichaeld factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT millerocuinjenniferl factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT driedgermichaelr factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT beckmanmichaelj factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT mckillopiainh factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT bakererinh factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT martiniejohnb factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT vrochidesdionisios factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT iannittidavida factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase
AT ocuinleem factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase